NICE backs Aimmune’s peanut allergy drug Palforzia for children
pharmaphorum
DECEMBER 23, 2021
Children in England with peanut allergies could be among the first in Europe to get access to Aimmune’s oral immunotherapy Palforzia, after the drugmaker agreed a supply deal with NHS England. billion last year, is also developing immunotherapies for other indications including egg and multi-tree nut allergies.
Let's personalize your content